Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)

NCT07569198 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Borderline Personality Disorder (BPD)
Treatment-Resistant Major Depressive Disorder
Treatment-resistant Bipolar Depression
Major Depressive Disorder (MDD)
Bipolar Disorder (BD)
Bipolar Disorder I or II
Suicidal Ideation

Interventions

DRUG: Ketamine Hydrochloride
DRUG: Midazolam Hydrochloride
BEHAVIORAL: Dialectical Behavioral Therapy (DBT)

Sponsor

Joshua Rosenblat